Aclaris Therapeutics, Inc.
ACRS
23 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 27 11:27 PM | Braden Michael Leonard10% Owner | Sale | 300,000 | $4.53 | $1.4M | 13,950,000(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 8 8:15 PM | Andrew N SchiffDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 5, 2026 | Jun 8 8:15 PM | Anand MehraDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | Anand MehraDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | Andrew N SchiffDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| Jun 5, 2026 | Jun 8 8:15 PM | William D. HumphriesDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 5, 2026 | Jun 8 8:15 PM | Christopher P. MolineauxDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | William D. HumphriesDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | Christopher P. MolineauxDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| Jun 5, 2026 | Jun 8 8:15 PM | Vincent MilanoDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | Vincent MilanoDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| Jun 5, 2026 | Jun 8 8:15 PM | Maxine GowenDirector | Option Exercise | 11,580 | — | 0(D) | View → |
| Jun 4, 2026 | Jun 8 8:15 PM | Maxine GowenDirector | Grant/Award | 53,337 | $4.71 | 10,987(D) | View → |
| May 1, 2026 | May 5 8:15 PM | Jesse Wayne HallChief Medical Officer | Option Exercise | 36,375 | — | 109,125(D) | View → |
| Mar 1, 2026 | Mar 3 9:10 PM | Kevin BalthaserChief Financial Officer | Option Exercise | 2,375 | — | 0(D) | View → |
| Feb 2, 2026 | Feb 6 11:10 PM | Neal WalkerDirector, CEO | Grant/Award | 1,236,500 | $3.61 | 961,700(D) | View → |
| Feb 2, 2026 | Feb 6 11:08 PM | Hugh M. DavisDirector, President and COO | Grant/Award | 432,400 | $3.61 | 336,300(D) | View → |
| Feb 2, 2026 | Feb 6 11:06 PM | Roland Wilhelm KolbeckChief Scientific Officer | Grant/Award | 430,600 | $3.61 | 334,900(D) | View → |
| Feb 2, 2026 | Feb 6 11:04 PM | Jesse Wayne HallChief Medical Officer | Grant/Award | 441,400 | $3.61 | 343,300(D) | View → |
| Feb 2, 2026 | Feb 6 11:02 PM | James LoeropChief Business Officer | Grant/Award | 439,600 | $3.61 | 341,900(D) | View → |
| Feb 2, 2026 | Feb 6 11:00 PM | Kevin BalthaserChief Financial Officer | Grant/Award | 445,900 | $3.61 | 346,800(D) | View → |
Page 1 of 2
Next →